Fig. 4From: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort studyForest plot of all clinical outcomes at 5Â years in aspirin monotherapy users with NAFLD, sub-stratified by sexBack to article page